Strides Pharma Science Ltd.

Financial

	Strides Pharma Scien	FDC	Marksans Pharma
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	230.0 .	n/a	25.0 .
Number of ANDA's Approved By USFDA	215.0 .	n/a	13.0 .
R&D as a % of Total Sales	1.84 %	2.06 %	2.2 %
Financials
5 yr Average ROE	23.7 %	13.66 %	17.57 %
5yr average Equity Multiplier	2.62	1.57	1.33
5yr Average Asset Turnover Ratio	0.6	0.54	0.9
5yr Avg Net Profit Margin	12.9 %	16.24 %	14.56 %
Price to Book	3.02	3.4	4.13
P/E	21.25	29.06	26.74
5yr Avg Cash Conversion Cycle	-51.45 Days	-14.0 Days	71.65 Days
Inventory Days	69.05 Days	59.23 Days	89.77 Days
Days Receivable	60.35 Days	21.91 Days	65.99 Days
Days Payable	225.58 Days	86.54 Days	88.81 Days
5yr Average Interest Coverage Ratio	0.72	93.3	38.03
5yr Avg ROCE	10.5 %	14.95 %	21.95 %
5yr Avg Operating Profit Margin	12.17 %	18.97 %	20.32 %
5 yr average Debt to Equity	1.01	0.0	0.02
5yr CAGR Net Profit	68.01 %	4.94 %	10.03 %
5yr Average Return on Assets	10.97 %	8.73 %	13.19 %
Shareholdings
Promoter Holding	28.3 %	69.66 %	43.87 %
Share Pledged by Promoters	50.1 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.07 %	0.16 %	-4.38 %
Change in Mutual Fund Holding (3 Yrs)	-0.99 %	1.1 %	2.6 %

Business

	Strides Pharma Scien	FDC	Marksans Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Bulk Drugs 0 Formulation 0 Vitamins & Suppliments 0 Anti-Cancer 0 Anti-Hair Fall 0 Central Nervous System 0 Antibiotics 0 Anti-allergic 0 Miscellaneous 0 Gastro-intestinal 0 Anti-diabetic 0 Cough and colds 0 Cardiovascular system (CVS) 0 Pain management 0	Product Wise Break-Up Anti-allergic 0 Antibiotics 0 Gastro-intestinal 0 Cardiovascular system (CVS) 0 Miscellaneous 0 Formulations 85.53 Pain management 0 Pharmaceutical 0 Anti-Hair Fall 0 Vitamins & Suppliments 0 Central Nervous System 0 Bulk Chemicals 14.47 Anti-diabetic 0 Anti-Cancer 0 Cough and colds 0	Product Wise Break-Up Anti-allergic 0 Antibiotics 0 Gastro Intestinal 8.5 Cardiac Science 9.2 Miscellaneous 0 Formulation 0 Pain Management 44.0 Pharmaceutical 0 Anti-Hair Fall 0 Vitamins & Suppliments 0 Central Nervous System (CNS) 8.1 Bulk Drugs 0 Anti - Diabetes 1.6 Anti-Cancer 0 Cough and colds 14.0 Others 14.6
Location Wise Break-Up	Location Wise Break-Up North America 53.68 Europe 21.77 Africa 10.11 Australia 9.63 Asia Pacific 0.49 India 0.35 Ethiopia 0 Hong Kong 0 Malaysia 0 Japan 0 New Zealand 0 Nepal 0 Singapore 0 United Kingdom 0 Denmark 0 USA 0 Others 3.97	Location Wise Break-Up India 80.77 Japan 0 USA 7.76 Europe 0 Ethiopia 0 Singapore 0 New Zealand 0 Asia Pacific 0 North America 0 Hong Kong 0 United Kingdom 0 Australia 0 Africa 0 Nepal 0 Malaysia 0 Denmark 0 Others 11.47	Location Wise Break-Up India 0 Japan 0 USA 0 Europe 39.3 Ethiopia 0 Singapore 0 New Zealand 0 Asia Pacific 0 North America 47.1 Hong Kong 0 United Kingdom 0 Australia 9.6 Africa 0 Nepal 0 Malaysia 0 Denmark 0 Others 4.0
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical 100.0	-	-
Customer Segment	Customer Segment Regulated market 83.0 Emerging Market 11.0 Institutional Business 0 OTC 0 Rx 0 Others 6.0	-	Customer Segment Emerging Market 0 Institutional Business 0 Rx 21.2 OTC 78.8 Regulated market 0
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 43.68 Asia ex India 22.48 North America 18.17 Europe 10.2 Africa 5.48 Australia 0	-	-
Asset Break-Up	Asset Break-Up Pharmaceutical 97.35 Bio-Pharmaceutical 2.65	-	-

Strides Pharma Science Ltd.

Strides Pharma Science Ltd.

SIGN UP FOR FREE